Product Code: ETC13308381 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Enteric Disease Testing and Therapeutic Market was valued at USD 2.1 Billion in 2024 and is expected to reach USD 4.2 Billion by 2031, growing at a compound annual growth rate of 11.40% during the forecast period (2025-2031).
The Global Enteric Disease Testing and Therapeutic Market is experiencing steady growth due to the increasing prevalence of enteric diseases worldwide, such as cholera, typhoid fever, and gastroenteritis. The market encompasses a range of diagnostic tests, including stool tests, blood tests, and imaging tests, as well as therapeutic options like antibiotics, probiotics, and rehydration therapy. Factors driving market growth include rising awareness about the importance of early detection and treatment of enteric diseases, technological advancements in diagnostic techniques, and government initiatives to control the spread of these illnesses. Key players in the market are investing in research and development to introduce innovative testing methods and therapeutics, aiming to improve patient outcomes and reduce the burden of enteric diseases on healthcare systems globally.
The global enteric disease testing and therapeutic market is witnessing a surge in demand due to the increasing prevalence of enteric diseases such as cholera, typhoid, and norovirus worldwide. The market is experiencing growth opportunities driven by the rising awareness about the importance of early diagnosis and treatment of these diseases. Technological advancements in diagnostic methods, such as molecular testing and rapid diagnostic tests, are also contributing to market growth. Additionally, the focus on developing effective therapeutics and vaccines for enteric diseases presents significant opportunities for market players. With the increasing healthcare expenditure and initiatives by governments and organizations to control the spread of enteric diseases, the market is expected to continue its growth trajectory in the coming years.
The Global Enteric Disease Testing and Therapeutic Market faces challenges such as limited access to advanced diagnostic technologies in developing regions, inadequate infrastructure for proper sanitation and hygiene practices, and the emergence of drug-resistant strains of enteric pathogens. Additionally, the lack of awareness about enteric diseases among the general population and healthcare providers poses a challenge in timely diagnosis and treatment. Regulatory hurdles and stringent approval processes for new therapeutics also hinder the market growth. Furthermore, the high cost associated with diagnostic tests and treatment options, coupled with the limited healthcare budgets in some countries, present obstacles for market expansion. Addressing these challenges will require collaborative efforts among stakeholders to improve access to testing and treatment, enhance public health education, and develop innovative solutions to combat enteric diseases effectively.
The global enteric disease testing and therapeutic market is primarily driven by the increasing prevalence of enteric diseases worldwide, rising awareness about the importance of early diagnosis and treatment, and the advancements in diagnostic technologies such as molecular testing and immunoassays. Additionally, the growing demand for point-of-care testing solutions, improved healthcare infrastructure in developing countries, and initiatives by governments and healthcare organizations to control and prevent enteric diseases are contributing to the market growth. Moreover, the emergence of innovative therapeutic options and the focus on research and development activities aimed at developing more effective treatments are further propelling the market expansion. Overall, the market is expected to continue to grow due to the rising burden of enteric diseases and the efforts to improve diagnostic and treatment outcomes.
Government policies related to the Global Enteric Disease Testing and Therapeutic Market vary by country, but generally focus on improving access to diagnostic testing and treatment, as well as implementing strategies to prevent the spread of enteric diseases. Many governments have established surveillance programs to monitor the prevalence and incidence of enteric diseases, and have implemented regulations to ensure the quality and safety of diagnostic tests and therapies. Additionally, government funding and support for research and development in this field are aimed at advancing new technologies and treatments for enteric diseases. Overall, government policies in the Global Enteric Disease Testing and Therapeutic Market aim to address public health concerns, improve healthcare outcomes, and reduce the burden of enteric diseases on society.
The Global Enteric Disease Testing and Therapeutic Market is expected to witness substantial growth in the coming years due to increasing incidences of enteric diseases worldwide. Technological advancements in diagnostic testing methods, rising awareness about the importance of early detection, and the development of novel therapeutic solutions are driving market growth. The increasing demand for point-of-care testing and the rise in public health initiatives aimed at controlling enteric diseases will further propel market expansion. Additionally, the growing focus on personalized medicine and the emergence of innovative treatment options are anticipated to create opportunities for market players. However, challenges such as inadequate healthcare infrastructure in developing regions and the high cost of advanced diagnostic and therapeutic solutions may hinder market growth to some extent.
In the Global Enteric Disease Testing and Therapeutic Market, Asia is expected to witness significant growth due to the increasing incidence of enteric diseases, rising awareness about early diagnosis, and improving healthcare infrastructure. North America is likely to dominate the market owing to the presence of key players, high healthcare expenditure, and advanced diagnostic technologies. In Europe, the market is driven by the growing focus on preventive healthcare measures and government initiatives for disease control. The Middle East and Africa region is anticipated to experience steady growth with improving healthcare facilities and rising investments in healthcare infrastructure. Latin America is also projected to show growth due to the increasing prevalence of enteric diseases and the adoption of advanced diagnostic tools and therapeutics in the region.
Global Enteric Disease Testing and Therapeutic Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Enteric Disease Testing and Therapeutic Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Enteric Disease Testing and Therapeutic Market Revenues & Volume, 2021 & 2031F |
3.3 Global Enteric Disease Testing and Therapeutic Market - Industry Life Cycle |
3.4 Global Enteric Disease Testing and Therapeutic Market - Porter's Five Forces |
3.5 Global Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By Testing Type, 2021 & 2031F |
3.7 Global Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.8 Global Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.9 Global Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By Treatment Type, 2021 & 2031F |
3.10 Global Enteric Disease Testing and Therapeutic Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Enteric Disease Testing and Therapeutic Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Enteric Disease Testing and Therapeutic Market Trends |
6 Global Enteric Disease Testing and Therapeutic Market, 2021 - 2031 |
6.1 Global Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Testing Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Molecular Testing, 2021 - 2031 |
6.1.3 Global Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Stool Culture, 2021 - 2031 |
6.1.4 Global Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Serological Testing, 2021 - 2031 |
6.1.5 Global Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Rapid Testing Kits, 2021 - 2031 |
6.2 Global Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Gastroenteritis, 2021 - 2031 |
6.2.3 Global Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Cholera, 2021 - 2031 |
6.2.4 Global Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Salmonella Infection, 2021 - 2031 |
6.2.5 Global Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By E. Coli Infection, 2021 - 2031 |
6.3 Global Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By End User, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 Global Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Research Labs, 2021 - 2031 |
6.3.4 Global Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Diagnostic Centers, 2021 - 2031 |
6.3.5 Global Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Clinics, 2021 - 2031 |
6.4 Global Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Global Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Antiviral Therapy, 2021 - 2031 |
6.4.3 Global Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Antibiotic Therapy, 2021 - 2031 |
6.4.4 Global Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Probiotic Therapy, 2021 - 2031 |
6.4.5 Global Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Vaccine Therapy, 2021 - 2031 |
6.5 Global Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.5.1 Overview & Analysis |
6.5.2 Global Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Hospital Pharmacies, 2021 - 2031 |
6.5.3 Global Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Specialty Pharmacies, 2021 - 2031 |
6.5.4 Global Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Online Retail, 2021 - 2031 |
6.5.5 Global Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Direct Sales, 2021 - 2031 |
7 North America Enteric Disease Testing and Therapeutic Market, Overview & Analysis |
7.1 North America Enteric Disease Testing and Therapeutic Market Revenues & Volume, 2021 - 2031 |
7.2 North America Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Enteric Disease Testing and Therapeutic Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Enteric Disease Testing and Therapeutic Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Enteric Disease Testing and Therapeutic Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Testing Type, 2021 - 2031 |
7.4 North America Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.5 North America Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By End User, 2021 - 2031 |
7.6 North America Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
7.7 North America Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Enteric Disease Testing and Therapeutic Market, Overview & Analysis |
8.1 Latin America (LATAM) Enteric Disease Testing and Therapeutic Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Enteric Disease Testing and Therapeutic Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Enteric Disease Testing and Therapeutic Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Enteric Disease Testing and Therapeutic Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Enteric Disease Testing and Therapeutic Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Testing Type, 2021 - 2031 |
8.4 Latin America (LATAM) Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
8.5 Latin America (LATAM) Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By End User, 2021 - 2031 |
8.6 Latin America (LATAM) Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
8.7 Latin America (LATAM) Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Enteric Disease Testing and Therapeutic Market, Overview & Analysis |
9.1 Asia Enteric Disease Testing and Therapeutic Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Enteric Disease Testing and Therapeutic Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Enteric Disease Testing and Therapeutic Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Enteric Disease Testing and Therapeutic Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Enteric Disease Testing and Therapeutic Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Testing Type, 2021 - 2031 |
9.4 Asia Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
9.5 Asia Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By End User, 2021 - 2031 |
9.6 Asia Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
9.7 Asia Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Enteric Disease Testing and Therapeutic Market, Overview & Analysis |
10.1 Africa Enteric Disease Testing and Therapeutic Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Enteric Disease Testing and Therapeutic Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Enteric Disease Testing and Therapeutic Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Enteric Disease Testing and Therapeutic Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Enteric Disease Testing and Therapeutic Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Testing Type, 2021 - 2031 |
10.4 Africa Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
10.5 Africa Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By End User, 2021 - 2031 |
10.6 Africa Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
10.7 Africa Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Enteric Disease Testing and Therapeutic Market, Overview & Analysis |
11.1 Europe Enteric Disease Testing and Therapeutic Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Enteric Disease Testing and Therapeutic Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Enteric Disease Testing and Therapeutic Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Enteric Disease Testing and Therapeutic Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Enteric Disease Testing and Therapeutic Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Testing Type, 2021 - 2031 |
11.4 Europe Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
11.5 Europe Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By End User, 2021 - 2031 |
11.6 Europe Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
11.7 Europe Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Enteric Disease Testing and Therapeutic Market, Overview & Analysis |
12.1 Middle East Enteric Disease Testing and Therapeutic Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Enteric Disease Testing and Therapeutic Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Enteric Disease Testing and Therapeutic Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Enteric Disease Testing and Therapeutic Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Testing Type, 2021 - 2031 |
12.4 Middle East Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
12.5 Middle East Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By End User, 2021 - 2031 |
12.6 Middle East Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Treatment Type, 2021 - 2031 |
12.7 Middle East Enteric Disease Testing and Therapeutic Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Enteric Disease Testing and Therapeutic Market Key Performance Indicators |
14 Global Enteric Disease Testing and Therapeutic Market - Export/Import By Countries Assessment |
15 Global Enteric Disease Testing and Therapeutic Market - Opportunity Assessment |
15.1 Global Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By Testing Type, 2021 & 2031F |
15.3 Global Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
15.4 Global Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By End User, 2021 & 2031F |
15.5 Global Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By Treatment Type, 2021 & 2031F |
15.6 Global Enteric Disease Testing and Therapeutic Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Enteric Disease Testing and Therapeutic Market - Competitive Landscape |
16.1 Global Enteric Disease Testing and Therapeutic Market Revenue Share, By Companies, 2024 |
16.2 Global Enteric Disease Testing and Therapeutic Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |